I don't believe the revenue is going to get capped. The potential for up selling future products and targeted selling is massive. Also, the untapped potential when this goes international will see revenue from all angles.
I'm seeing that the GP Link is already punching on and successful. I would doubt that they would be launching it at the Royal Australian College of General Practitioners conference if this wasn't pumping.
If pharmacy uptake continues to grow at this rate, the barriers to entry for any competitor will be high. Medadvisor are monopolising this market. Solid medium to long term hold here.
Add to My Watchlist
What is My Watchlist?
